X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
animals (21) 21
mice (19) 19
humans (16) 16
cancer (11) 11
mice, nude (10) 10
cell line, tumor (9) 9
tumors (9) 9
female (8) 8
medicine & public health (6) 6
oncology (6) 6
research (6) 6
angiogenesis (5) 5
brain neoplasms - genetics (5) 5
cell biology (5) 5
expression (5) 5
glioblastoma (5) 5
male (5) 5
pathology (5) 5
abridged index medicus (4) 4
clinical neurology (4) 4
disease models, animal (4) 4
glioma - metabolism (4) 4
magnetic resonance imaging (4) 4
mice, inbred c57bl (4) 4
neoplasm transplantation (4) 4
neurosciences (4) 4
phenotype (4) 4
physiological aspects (4) 4
tumor (4) 4
xenograft model antitumor assays (4) 4
brain neoplasms - drug therapy (3) 3
brain neoplasms - metabolism (3) 3
brain neoplasms - pathology (3) 3
brain tumors (3) 3
chemotherapy (3) 3
differentiation (3) 3
gene expression (3) 3
gene expression regulation, neoplastic (3) 3
genetic aspects (3) 3
glioma - pathology (3) 3
growth (3) 3
hek293 cells (3) 3
imaging / radiology (3) 3
inhibition (3) 3
multidisciplinary sciences (3) 3
mutation (3) 3
neovascularization, pathologic - metabolism (3) 3
neovascularization, pathologic - pathology (3) 3
prognosis (3) 3
radiology, nuclear medicine & medical imaging (3) 3
temozolomide (3) 3
therapy (3) 3
ultrasound (3) 3
xenografts (3) 3
activation (2) 2
adolescent (2) 2
animals, newborn (2) 2
antiangiogenic therapy (2) 2
antibodies (2) 2
arteriovenous-malformations (2) 2
article (2) 2
astrocytoma - enzymology (2) 2
astrocytoma - genetics (2) 2
blood-vessels (2) 2
brain (2) 2
brain neoplasms - enzymology (2) 2
breast-cancer (2) 2
care and treatment (2) 2
cell culture (2) 2
cell migration (2) 2
cell proliferation (2) 2
comparative genomic hybridization (2) 2
diagnostic radiology (2) 2
disease progression (2) 2
endothelial cells - metabolism (2) 2
endothelial growth-factor (2) 2
gene (2) 2
gene expression profiling (2) 2
glioblastoma - drug therapy (2) 2
glioma (2) 2
glioma - genetics (2) 2
glioma-cells (2) 2
gliomas (2) 2
hsa-mir-182 (2) 2
human necessities (2) 2
hygiene (2) 2
hypoxia (2) 2
in vitro techniques (2) 2
in-vitro (2) 2
in-vivo (2) 2
internal medicine (2) 2
interventional radiology (2) 2
isocitrate dehydrogenase - genetics (2) 2
lymphocytes (2) 2
management (2) 2
manufacture or treatment of nanostructures (2) 2
measurement or analysis of nanostructures (2) 2
medical or veterinary science (2) 2
medicine, research & experimental (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 07/2013, Volume 19, Issue 7, pp. 901 - 908
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2014, Volume 111, Issue 1, pp. 409 - 414
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 4/2017, Volume 133, Issue 4, pp. 629 - 644
Mutations in codon 132 of isocitrate dehydrogenase (IDH) 1 are frequent in diffuse glioma, acute myeloid leukemia, chondrosarcoma and intrahepatic... 
Pathology | Therapy | Neurosciences | IDH-mutated glioma | Medicine & Public Health | IDH1R132 inhibitor | Pharmacology | Drug development | Mouse xenograft | SELECTIVE-INHIBITION | GLIOMAS | ISOCITRATE DEHYDROGENASE | PHENOTYPE | ACUTE MYELOID-LEUKEMIA | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | BRAIN-TUMORS | GLIOBLASTOMAS | TUMOR STEM-CELLS | MUTATIONS | DIFFERENTIATION | Benzimidazoles - toxicity | Colonic Neoplasms - genetics | Colonic Neoplasms - drug therapy | Escherichia coli | Humans | Sarcoma - enzymology | Benzimidazoles - chemistry | Isocitrate Dehydrogenase - antagonists & inhibitors | Antineoplastic Agents - toxicity | Sf9 Cells | Enzyme Inhibitors - pharmacokinetics | Enzyme Inhibitors - chemistry | Enzyme Inhibitors - toxicity | Astrocytoma - drug therapy | HEK293 Cells | Astrocytoma - enzymology | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Sarcoma - genetics | Cell Survival - physiology | Astrocytoma - genetics | Recombinant Proteins - metabolism | Cell Survival - drug effects | Brain Neoplasms - enzymology | Aniline Compounds - pharmacology | Enzyme Inhibitors - pharmacology | Benzimidazoles - pharmacokinetics | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Recombinant Proteins - genetics | Aniline Compounds - pharmacokinetics | Aniline Compounds - toxicity | Antineoplastic Agents - chemistry | Brain Neoplasms - drug therapy | Sarcoma - drug therapy | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cell Line, Tumor | Benzimidazoles - pharmacology | Isocitrate Dehydrogenase - metabolism | Colonic Neoplasms - enzymology | Glutarates - metabolism | Mice, Inbred BALB C | Aniline Compounds - chemistry | Mutation | Gliomas | Genetic aspects | Codon | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 10/2011, Volume 478, Issue 7368, pp. 197 - 203
Journal Article
Journal Article
Journal Article
Cancer Cell, ISSN 1535-6108, 12/2014, Volume 26, Issue 6, pp. 880 - 895
Journal Article
Journal Article
CardioVascular and Interventional Radiology, ISSN 0174-1551, 06/2019, Volume 42, Issue 6, p. 905
To investigate the novel zein-based non-adhesive precipitating liquid embolic HEI.sub.E1_2017. HEI.sub.E1_2017 is a promising novel zein-based liquid embolic.... 
Biopolymers
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 11/2011, Volume 122, Issue 5, pp. 637 - 650
Incompletely resectable ependymomas are associated with poor prognosis despite intensive radio- and chemotherapy. Novel treatments have been difficult to... 
Pathology | Neurosciences | Histone deacetylase inhibitor | Medicine & Public Health | Cancer stem cells | Differentiation | Ependymoma | ABNORMALITIES | TUMOR | PATHOLOGY | IDENTIFICATION | CHILDHOOD | NEUROSCIENCES | CLINICAL NEUROLOGY | CHILDREN | GROWTH-FACTOR RECEPTOR | PLASMA | INTRACRANIAL EPENDYMOMAS | PHASE-I | EXPRESSION | Supratentorial Neoplasms - pathology | Humans | Histone Deacetylase Inhibitors - administration & dosage | Injections, Intraventricular | Neural Stem Cells - drug effects | Transplantation, Heterologous | Gene Expression Profiling | Neural Stem Cells - pathology | Phenotype | Animals | Cell Differentiation - drug effects | Models, Biological | Cell Line, Tumor | Hydroxamic Acids - administration & dosage | Ependymoma - pathology | Histone Deacetylase Inhibitors - pharmacology | Mice | In Vitro Techniques | Hydroxamic Acids - pharmacology | Chemotherapy | Molecular genetics | Neurons | Oncology, Experimental | Brain tumors | Stem cells | Transplantation | Research | Universities and colleges | Metastasis | Biometry | Cancer | Index Medicus | temozolomide | Cell culture | Histone deacetylase | Prognosis | Risk groups | Gene expression | Vincristine | Cisplatin | Metastases | Plasticity (neural) | Molecular modelling | Xenografts | Tumors | ependymoma | differentiation | cancer stem cells | histone deacetylase inhibitor
Journal Article